Health

RESEARCH SUMMARY :

This group is working on proposals related to the FP7-HEALTH-Cooperation Program:

• HEALTH.2011.2.4.1-1: Investigator-driven, treatment trials24 for rare cancers.

• HEALTH.2011.2.4.1-2: Translational research on cancers with poor prognosis.

Key words : stem cells, solid tumors, chemo and radio therapy resistance, recurrence, therapy of differentiation, new drug development.

Research groups involved:

• UCLM Neuropharmacology Group
• UCLM Neurochemistry Group
• UCLM Laboratory of Human Neuroanatomy
• UCLM Laboratory of molecular oncology
• UCLM Cellular and Molecular Biology of Stem Cell Group
• UMINHO Chemistry Department
• UNILIM Cellular Homeostasis and Pathologies Group
• UMHE Neurosciences Institute, Alterad molecular mechanism in Alzheimer disease
• UPM Centre for Biomedical Technology
• UPNA Health Sciences
• UPNA Statistics and econometrics

External partners

• Adam Mickiewicz University of Poland, Institute of Molecular Biology and Biotechnology
• University of Cambridge, WellcomeTrust Centre for S.C. Research, Epithelial Stem Cell Homeostasis and Cancer Research Group.
• Cambridge Research Center, Mammary Stem Cell Biology Group.
• INBIOMED Regulation of Cell Growth Laboratory – Cancer Programme.
• CORUÑA Hospital, Oncología

Related events:

• 10.03.2010, workshop, Albacete – participants: UCLM, UNILIM, UMINHO, UMHE, Adam Mickiewicz Univ. Poland, Univ. of Cambridge, Cambridge Research Institute, Inbiomed, Coruña hospital.
• 28.04.2010, workshop, Madrid – participants: UPM/UPNA
• Workshop, October 2010, Limoges (to come)

For more information: Joaquin.jordan uclm.es